Literature DB >> 1346385

Preferential mutation of the neurofibromatosis type 1 gene in paternally derived chromosomes.

K Stephens1, L Kayes, V M Riccardi, M Rising, V P Sybert, R A Pagon.   

Abstract

An interesting feature of neurofibromatosis type 1 (NF1) is its high mutation rate of 1 x 10(-4) per gamete per generation. The molecular basis for frequent NF1 mutation in unknown; the gene is not deletion prone. We have found that in all ten families examined, the apparent new NF1 mutation occurred on the paternally-derived chromosome. The probability of observing this result by chance is less than 0.001 assuming an equal frequency of mutation of paternal and maternal NF1 genes. We hypothesize a role for genomic imprinting that may either enhance mutation of the paternal NF1 gene or confer protection from mutation to the maternal NF1 gene.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1346385     DOI: 10.1007/bf00197259

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  26 in total

1.  Genetic analysis of NF1: identification of close flanking markers on chromosome 17.

Authors:  P R Fain; D F Barker; D E Goldgar; E Wright; K Nguyen; J Carey; J Johnson; J Kivlin; H Willard; C Mathew
Journal:  Genomics       Date:  1987-12       Impact factor: 5.736

2.  Identification of more than 500 RFLPs by screening random genomic clones.

Authors:  J W Schumm; R G Knowlton; J C Braman; D F Barker; D Botstein; G Akots; V A Brown; T C Gravius; C Helms; K Hsiao
Journal:  Am J Hum Genet       Date:  1988-01       Impact factor: 11.025

3.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

4.  Parental origin of mutations of the retinoblastoma gene.

Authors:  T P Dryja; S Mukai; R Petersen; J M Rapaport; D Walton; D W Yandell
Journal:  Nature       Date:  1989-06-15       Impact factor: 49.962

5.  Recurrence risk of a new dominant mutation in children of unaffected parents.

Authors:  E M Wijsman
Journal:  Am J Hum Genet       Date:  1991-04       Impact factor: 11.025

6.  Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus.

Authors:  D Viskochil; A M Buchberg; G Xu; R M Cawthon; J Stevens; R K Wolff; M Culver; J C Carey; N G Copeland; N A Jenkins
Journal:  Cell       Date:  1990-07-13       Impact factor: 41.582

7.  Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17.

Authors:  D Barker; E Wright; K Nguyen; L Cannon; P Fain; D Goldgar; D T Bishop; J Carey; B Baty; J Kivlin
Journal:  Science       Date:  1987-05-29       Impact factor: 47.728

8.  The pathophysiology of neurofibromatosis: IX. Paternal age as a factor in the origin of new mutations.

Authors:  V M Riccardi; C E Dobson; R Chakraborty; C Bontke
Journal:  Am J Med Genet       Date:  1984-05

9.  Multipoint linkage analysis in neurofibromatosis type I: an international collaboration.

Authors:  D E Goldgar; P Green; D M Parry; J J Mulvihill
Journal:  Am J Hum Genet       Date:  1989-01       Impact factor: 11.025

10.  Molecular characterisation of a hypervariable region downstream of the human alpha-globin gene cluster.

Authors:  A P Jarman; R D Nicholls; D J Weatherall; J B Clegg; D R Higgs
Journal:  EMBO J       Date:  1986-08       Impact factor: 11.598

View more
  27 in total

1.  Two pathogenic NF1 gene mutations identified in DNA from a child with mild phenotype.

Authors:  Yunus Kasim Terzi; Burcu Sirin; Guzen Hosgor; Esra Serdaroglu; Banu Anlar; Sabiha Aysun; Sukriye Ayter
Journal:  Childs Nerv Syst       Date:  2011-12-09       Impact factor: 1.475

2.  Perioperative management of neurofibromatosis type 1.

Authors:  Charles J Fox; Samir Tomajian; Aaron J Kaye; Stephanie Russo; Jacqueline Volpi Abadie; Alan D Kaye
Journal:  Ochsner J       Date:  2012

3.  A cytogenetic deletion, del(17)(q11.22q21.1), in a patient with sporadic neurofibromatosis type 1 (NF1) associated with dysmorphism and developmental delay.

Authors:  M Upadhyaya; S H Roberts; J Maynard; E Sorour; P W Thompson; M Vaughan; A O Wilkie; H E Hughes
Journal:  J Med Genet       Date:  1996-02       Impact factor: 6.318

4.  The mutational spectrum of the NF1 gene in neurofibromatosis type I patients from UAE.

Authors:  Salma Ben-Salem; Aisha M Al-Shamsi; Bassam R Ali; Lihadh Al-Gazali
Journal:  Childs Nerv Syst       Date:  2014-01-11       Impact factor: 1.475

5.  Clinical and molecular characteristics of thirty NF1 variants in Chinese patients with neurofibromatosis type 1.

Authors:  Wen Wang; Weibing Qin; Hongsong Ge; Xiangsheng Kong; Chao Xie; Yunge Tang; Ming Li
Journal:  Mol Biol Rep       Date:  2019-06-14       Impact factor: 2.316

6.  Somatic mosaicism in a patient with neurofibromatosis type 1.

Authors:  S D Colman; S A Rasmussen; V T Ho; C R Abernathy; M R Wallace
Journal:  Am J Hum Genet       Date:  1996-03       Impact factor: 11.025

7.  Large de novo DNA deletion in a patient with sporadic neurofibromatosis 1, mental retardation, and dysmorphism.

Authors:  L M Kayes; V M Riccardi; W Burke; R L Bennett; K Stephens
Journal:  J Med Genet       Date:  1992-10       Impact factor: 6.318

Review 8.  Molecular genetics of neurofibromatosis type 1 (NF1).

Authors:  M H Shen; P S Harper; M Upadhyaya
Journal:  J Med Genet       Date:  1996-01       Impact factor: 6.318

9.  Parent-of-origin effects in multiple endocrine neoplasia type 2B.

Authors:  K M Carlson; J Bracamontes; C E Jackson; R Clark; A Lacroix; S A Wells; P J Goodfellow
Journal:  Am J Hum Genet       Date:  1994-12       Impact factor: 11.025

10.  Characterisation of germline mutations in the neurofibromatosis type 1 (NF1) gene.

Authors:  M Upadhyaya; J Maynard; M Osborn; S M Huson; M Ponder; B A Ponder; P S Harper
Journal:  J Med Genet       Date:  1995-09       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.